Warehouse Overstock Promotion |  Save 10%  on Premium Lab Supplies |  Shop Now

Menu

This product has been added to the cart.

TGFBI Polyclonal Antibody Reactivity Human

SKU: E-AB-52170-200

  • $ 26595
  • Save $ 800


Request a Quote

TGFBI Polyclonal Antibody Reactivity Human

 

SKU # E-AB-52170
Reactivity Human, Mouse
Host Rabbit
Applications WB, IHC

 

Product Details

Isotype IgG
Host Rabbit
Reactivity Human, Mouse
Applications WB, IHC
Clonality Polyclonal
Immunogen Fusion protein of human TGFBI
Abbre TGFBI
Synonyms >RGD containing collagen associated protein,  AI181842,  AI747162,  BGH3,  BIGH3,  Beta ig,  Beta ig h3,  Beta ig-h3,  Big h3,  CDB1,  CDG2,  CDGG1,  CSD,  CSD1,  CSD2,  CSD3,  EBMD,  Kerato epithelin,  Kerato-epithelin,  LCD1,  MGC150270,  RGD CAP,  RGD-CAP,  RGD-containing collagen-associated prote
Swissprot
Calculated MW 75 kDa
Observed MW Refer to figures
Cellular Localization Secreted>extracellular space>extracellular matrix. May be associated both with microfibrils and with the cell surface.
Concentration 1.32 mg/mL
Buffer Phosphate buffered solution, pH 7.4, containing 0.05% stabilizer and 50% glycerol.
Purification Method Antigen affinity purification
Research Areas Cancer,  Developmental Biology,  Neuroscience,  Signal Transduction
Conjugation Unconjugated
Storage Store at -20°C Valid for 12 months. Avoid freeze / thaw cycles.
Shipping The product is shipped with ice pack, upon receipt, store it immediately at the temperature recommended.

 

Related Reagents

Applications Recommended Dilution
WB 1:500-1:2000
IHC 1:50-1:200

 

Background

TGFBI,also named as BIGH3,Kerato-epithelin and RGD-CAP,binds to type I,II,and IV collagens. TGFBI is an adhesion protein which may play an important role in cell-collagen interactions. In cartilage,it may be involved in endochondral bone formation. TGFBI is an extracellular matrix adaptor protein,it has been reported to be differentially expressed in transformed tissues. TGFBI is a predictive factor of the response to chemotherapy,and suggest the use of TGFBI-derived peptides as possible therapeutic adjuvants for the enhancement of responses to chemotherapy. Defects in TGFBI are the cause of epithelial basement membrane corneal dystrophy (EBMD). Defects in TGFBI are the cause of corneal dystrophy Groenouw type 1 (CDGG1). Defects in TGFBI are the cause of corneal dystrophy lattice type 1 (CDL1). Defects in TGFBI are a cause of corneal dystrophy Thiel-Behnke type (CDTB). Defects in TGFBI are the cause of Reis-Buecklers corneal dystrophy (CDRB). Defects in TGFBI are the cause of lattice corneal dystrophy type 3A (CDL3A). Defects in TGFBI are the cause of Avellino corneal dystrophy (ACD).